Richard P Darveau

Title: Richard P. Darveau: Innovator in Gingivitis Diagnosis and Treatment

Introduction

Richard P. Darveau is a notable inventor based in Camano Island, Washington. He has made significant contributions to the field of dental health, particularly in the diagnosis and treatment of gingivitis. His innovative approach has the potential to improve oral care for many individuals.

Latest Patents

Richard P. Darveau holds a patent for a biomarker of gingivitis diagnosis and treatment. This patent outlines methods for identifying individuals as either slow or high responders to gingivitis. Some of the methods are based on IL-1β levels in the individual's gingival crevicular fluid (GCF) at the site of inflammation. Other methods focus on MIF and/or CCL-1 levels in the GCF from healthy tissue distant from the site of inflammation. Additionally, the patent describes methods based on temporal differences in IL-8, IL-6, and/or TNFα levels in the GCF during the development of plaque-induced inflammation. The patent also includes methods for treating and preventing gingivitis by determining the responder type and applying appropriate oral care compositions.

Career Highlights

Richard P. Darveau is associated with Colgate-Palmolive Company, where he continues to work on innovative solutions for dental health. His expertise and research have contributed to advancements in oral care products and methodologies.

Collaborations

Richard has collaborated with notable colleagues, including Dandan Chen and Harsh Mahendra Trivedi. Their combined efforts in research and development have furthered the understanding of gingivitis and its treatment.

Conclusion

Richard P. Darveau's work in gingivitis diagnosis and treatment exemplifies the impact of innovation in dental health. His contributions are paving the way for improved oral care solutions that can benefit many individuals.